Research on nasopharyngeal carcinoma has shown that serum ApoA1 level higher than 1.025 g/L is an independent predictor of longer overall survival, less local recurrence or distant metastasis in patients [24]. The gene discussed is APOA1; the disease is nasopharyngeal carcinoma.